Navigation Links
Borderline blood pressure- possible health risk

It is best to keep blood pressure at normal (120/80 mmHg). Better still, there is a benefit in keeping blood pressure as low as possible.High blood pressure is generally defined as a reading above 140/90 mm Hg and, if untreated, it raises the risk of stroke and heart attack. It's becoming increasingly clear that these figures don't represent a clear cut-off point below which there's no health risk. Research is now focussing upon the high normal or borderline group, with blood pressure of less than 140/90 but more than 130/85.//

Generally research studies show that people who have high normal blood pressure have an increased risk of death from heart attack or stroke, compared to those with optimal - 120/80 or low blood pressure. An ongoing study reveals that borderline blood pressure also increases the risk of non-fatal cardiovascular events.

The researchers, Boston University, studied nearly men and women, dividing them into three groups on the basis of blood pressure: borderline and optimal, as defined above, and an in-between group defined as normal where blood pressure lay between 130 and 120 (top figure) and 70 and 80 (bottom figure). Over the 12 years following initial blood pressure measurement, rates of cardiovascular events were1.5 per cent, 2.2 per cent and 4.1 per cent for women depending on whether blood pressure was optimal, normal or borderline. The figures for men were: 5.1 per cent, 6 per cent and 10 per cent.


'"/>




Page: 1

Related medicine news :

1. Infant receives first bloodless liver transplant
2. Spouses and other partners lower blood pressure says new research
3. H2O - a cure for low blood pressure
4. Uncontrolled blood pressure
5. Nitric oxide involved in high blood pressure
6. Recouping blood flow after a stroke
7. Way to monitor blood pressure
8. Drugs disrupt formation of blood vessels
9. Gene therapy - Aim to improve blood flow
10. New Drug ALT-711 decreases blood vessel stiffness
11. Aggressive blood pressure treatment needed
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/18/2017)... ... August 18, 2017 , ... ... LLC (“Quick”), a highly specialized asset-light logistics provider of complex transport solutions ... definitive agreement to purchase Unitrans International Corporation, a division of Roadrunner Transportation ...
(Date:8/18/2017)... (PRWEB) , ... August 18, 2017 , ... ... this summer’s edition of “Vision & Hearing,” advocating for active, healthy lifestyles and ... on resources available for individuals with hearing impairments and shares the latest innovations ...
(Date:8/18/2017)... , ... August 18, 2017 , ... ... handling handheld devices. Through an educational webinar, they will present the line of ... chance to learn how easy you can automate everyday pipetting tasks. , Ideal ...
(Date:8/18/2017)... ... August 18, 2017 , ... Hernandez Insurance Agencies, a northern ... the greater DC region, is inaugurating a “New Leash On Life” charity initiative ... training them to be companions for veterans in need. , The Semper K9 ...
(Date:8/18/2017)... ... 18, 2017 , ... Moore Insurance, a Houston area agency ... is launching a regional charity effort to provide publicity assistance and generate donations ... Tumor Foundation (PBTF) has raised nearly $30 million in donations that has been ...
Breaking Medicine News(10 mins):
(Date:7/28/2017)... 2017 Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: HRC), ... ended June 30, 2017, and updated its financial outlook ... For the fiscal third quarter, Hill-Rom reported earnings ... diluted share in the prior-year period. These results reflect ... diluted share primarily related to the non-cash write-down of ...
(Date:7/27/2017)... July 27, 2017  West Pharmaceutical Services, Inc. (NYSE: ... for the second-quarter 2017 and updated financial guidance for ... Second-Quarter 2017 Highlights Reported net sales ... the prior-year quarter. Net sales at constant currency (organic) ... EPS was $0.51, compared to $0.60 in the prior-year ...
(Date:7/26/2017)... , July 26, 2017 Sancilio Pharmaceuticals Company, ... our clinical trial evaluating Altemia TM , an oral ... and Sickle Cell Disease (SCD). The SCOT Trial, is ... efficacy and safety of Altemia TM in pediatric ... under US IND 125274. ...
Breaking Medicine Technology: